This study analyzed the correlation between patient and tumor characteristics, age, parity, menopausal status, ER-PR expression, HER2/neu overexpression or amplification, and histological types and their impact on tumor behavior, treatment response, and overall survival. The gene discussed is ERBB2; the disease is neoplasm.